Počet záznamov: 1
LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN
SYS 0176121 LBL 00000naa^^22^^^^^^^^450 005 20211217134828.2 100 $a 20211020d2021 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN $f Li-Hui Yang ... [et al.] 215 $c ilustr., aj fareb., grafy, obr. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0175762 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 68, no. 4 (2021), s. 788-797 $1 210 $a Bratislava $c AEPress $d 2021 $1 215 $a s. 673-898 606 1-
$3 sllk_un_auth*d009101 $a myelóm mnohopočetný $2 mesh 606 1-
$3 sllk_un_auth*d062085 $a RNA dlhá nekódujúca $2 mesh 606 1-
$3 sllk_un_auth*d019008 $a rezistencia lieková nádorová $2 mesh 606 2-
$3 sllk_un_auth*d000069286 $a bortezomib $2 mesh 606 2-
$3 sllk_un_auth*d051059 $a PTEN fosfohydroláza $2 mesh 606 2-
$3 sllk_un_auth*d045744 $a línia bunková nádorová $2 mesh 610 2-
$a lncRNA ANRIL 610 2-
$a model nádoru xenograftový 610 2-
$a štúdia experimentálna 701 -1
$3 sllk_un_auth*0054603 $a Yang $b Li-Hui $4 070 801 -0
$a SK $b BA006 $c 20211020 $g AACR2
Počet záznamov: 1